Maternal antibody response, neutralizing potency, and placental antibody transfer after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
NT Joseph, CM Dude, HP Verkerke… - Obstetrics & …, 2021 - journals.lww.com
OBJECTIVE: To characterize maternal immune response after severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and quantify the …
syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and quantify the …
Determinants of neutralizing antibody response after SARS CoV-2 vaccination in patients with myeloma
AK Nooka, U Shanmugasundaram… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Vaccine-induced neutralizing antibodies (nAbs) play a critical role in protection
from SARS CoV-2. Patients with B-cell malignancies including myeloma are at increased …
from SARS CoV-2. Patients with B-cell malignancies including myeloma are at increased …
Laboratory-based SARS-CoV-2 receptor binding domain serologic assays perform with equivalent sensitivity and specificity to commercial FDA-EUA approved tests
During early phases of the SARS-CoV-2 epidemic, many research laboratories repurposed
their efforts towards developing diagnostic testing that could aid public health surveillance …
their efforts towards developing diagnostic testing that could aid public health surveillance …
Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice
PE Zerra, SR Patel, RP Jajosky… - Blood, The Journal …, 2021 - ashpublications.org
Red blood cell (RBC) transfusions can result in alloimmunization toward RBC alloantigens
that can increase the probability of complications following subsequent transfusion. An …
that can increase the probability of complications following subsequent transfusion. An …
Usefulness of IVD kits for the assessment of SARS-CoV-2 antibodies to evaluate the humoral response to vaccination
K Lukaszuk, J Kiewisz, K Rozanska, M Dabrowska… - Vaccines, 2021 - mdpi.com
Background: The introduction of the vaccination against SARS-CoV-2 infection creates the
need for precise tools for the quality control of vaccination procedures, detection of poor …
need for precise tools for the quality control of vaccination procedures, detection of poor …
Blood group A enhances SARS-CoV-2 infection
SC Wu, CM Arthur, HM Jan, WF Garcia-Beltran… - Blood, 2023 - ashpublications.org
Among the risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
ABO (H) blood group antigens are among the most recognized predictors of infection …
ABO (H) blood group antigens are among the most recognized predictors of infection …
Comparing results of five SARS-CoV-2 antibody assays before and after the first dose of ChAdOx1 nCoV-19 vaccine among health care workers
S Jeong, N Lee, SK Lee, EJ Cho, J Hyun… - Journal of clinical …, 2021 - Am Soc Microbiol
Reliable results regarding serologic positivity for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are …
coronavirus 2 (SARS-CoV-2) antibody before and after AstraZeneca (AZ) vaccination are …
A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity
D Stern, TC Meyer, F Treindl, HW Mages, M Krüger… - Scientific Reports, 2023 - nature.com
Serological assays measuring antibodies against SARS-CoV-2 are key to describe the
epidemiology, pathobiology or induction of immunity after infection or vaccination. Of those …
epidemiology, pathobiology or induction of immunity after infection or vaccination. Of those …
Full-length galectin-3 is required for high affinity microbial interactions and antimicrobial activity
SC Wu, AD Ho, NA Kamili, J Wang… - Frontiers in …, 2021 - frontiersin.org
While adaptive immunity enables the recognition of a wide range of microbial antigens,
immunological tolerance limits reactively toward self to reduce autoimmunity. Some bacteria …
immunological tolerance limits reactively toward self to reduce autoimmunity. Some bacteria …
Comparing SARS-CoV-2 antibody responses after various COVID-19 vaccinations in healthcare workers
YK Kim, D Minn, SH Chang, JS Suh - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) vaccination began for healthcare workers in South
Korea at the end of February 2021. This study investigated severe acute respiratory …
Korea at the end of February 2021. This study investigated severe acute respiratory …